(주)메지온
| KRW bn | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.9 | 2.0 | 1.7 | 2.1 | 2.1 | 2.0 | 2.2 | 2.4 |
| Operating income | -4.0 | -3.5 | -3.5 | -4.7 | -5.1 | -4.6 | -4.5 | -4.2 |
| Net income | -11.6 | -3.3 | -1.9 | -5.1 | -24.6 | -5.3 | 7.7 | -7.4 |
| Cash from operations | – | – | – | – | – | – | – | – |
| Free cash flow | – | – | – | – | – | – | – | – |
| KRW bn | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 31.7 | 8.6 | 7.9 |
| Operating income | -14.5 | -14.3 | -16.8 |
| Net income | -12.7 | -19.5 | -34.9 |
| Cash from operations | – | – | – |
| Free cash flow | – | – | – |
| Gross margin | -210.6% |
| ROA | -30.0% |
| Liabilities / equity | 1.35x |
| Current ratio | 0.75x |
| Filing | Form | ||
|---|---|---|---|
| Mon 16 Nov 2026 | |||
| Quarterly Report — 2026.09 | 10-Q | ||
| Wed 04 Nov 2026 | |||
| Material Information for Investment Decisions 투자판단관련주요경영사항 (유데나필의 호주 특허권 양도 계약 체결) | 8-K | ||
| Thu 29 Oct 2026 | |||
| Insider Ownership Report | 4 | ||